Symptomatic hypocalcemia from oral sodium phosphate: a report of two cases

The use of oral sodium phosphate has, only in very rare instances (seven cases in the literature), been recognized to cause symptomatic hypocalcemia. We report a case in an elderly woman that led to severe tetany and a 10-day admission to control the electrolyte disturbances. The patient was predisposed to developing this complication because of chronic renal failure and vitamin D deficiency. The second hypocalcemic patient had perioral tingling and numbness of the extremities but recovered quickly because of normal renal function. Magnesium depletion was a predisposing factor in the second case. These cases illustrate the rising prevalence of this disorder, which can have severe consequences and can be prevented by avoiding the prescription of these agents to high risk patient groups.

[1]  T. G. Wood Oral Fleet® Phospho®-Soda: Doses and interval between them , 1997, Diseases of the colon and rectum.

[2]  R. Beart,et al.  Oral fleet® phospho®-soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult , 1997, Diseases of the colon and rectum.

[3]  W. Bennett,et al.  Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management. , 1996, Journal of the American Society of Nephrology : JASN.

[4]  P. Raval,et al.  Oral sodium phosphate catharsis and acute renal failure. , 1996, The American journal of gastroenterology.

[5]  M. N. Lassman,et al.  Severe Hyperphosphatemia Induced by a Phosphate-Containing Oral Laxative , 1996, The Annals of pharmacotherapy.

[6]  S. Achem,et al.  A comparison of the effectiveness and patient tolerance of oral sodium phosphate, castor oil, and standard electrolyte lavage for colonoscopy or sigmoidoscopy preparation. , 1993, The American journal of gastroenterology.

[7]  R. Fass,et al.  Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. , 1993, The American journal of gastroenterology.

[8]  M. Crooke,et al.  Disturbances of calcium and magnesium metabolism occur in most hyperthyroid patients. , 1989, Clinical biochemistry.

[9]  S. Vanner,et al.  Use of oral sodium phosphate colonic lavage solution by Canadian colonoscopists: pitfalls and complications. , 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[10]  W. Paterson,et al.  Safety profile of 5-h oral sodium phosphate regimen for colonoscopy cleansing: lack of clinically significant hypocalcemia or hypovolemia. , 1995, The American journal of gastroenterology.

[11]  D. E. Abrams,et al.  Hypocalcemic tetany due to sodium phosphate ingestion in acute renal failure. , 1975, Nephron.